Nicole LaBrosse
Director of Finance/CFO at HALOZYME THERAPEUTICS, INC.
Net worth: 810 533 $ as of 30/06/2024
Nicole LaBrosse active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 02/02/2022 | - |
| Comptroller/Controller/Auditor | 01/01/2017 | 02/02/2022 | |
| Director/Board Member | 01/01/2017 | 01/01/2020 | |
| ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 | - |
Career history of Nicole LaBrosse
Former positions of Nicole LaBrosse
| Companies | Position | Start | End |
|---|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01/01/2004 | 01/01/2015 |
Training of Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Statistics
International
| United States | 5 |
| Australia | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Stock Market
- Insiders
- Nicole LaBrosse
- Experience
